Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Pre-operative chemotherapy and radiotherapy in breast cancer

Autor: M, Colleoni, F, Nole, I, Minchella, C, Noberasco, A, Luini, R, Orecchia, P, Veronesi, S, Zurrida, G, Viale, A, Goldhirsch, A, Orecchia

Publikováno v: European Journal of Cancer. 34:641-645

Primary systemic treatment of breast cancer with cytotoxics yields a high response rate and allows conservative surgical procedures in bulky tumours. In order to maximise local control of disease, two innovations were introduced in a pilot study. The

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d3156ccdb475c5d58ac9df70facc7846
https://doi.org/10.1016/s0959-8049(97)10091-0

Contents, Vol. 52, 1995

Autor: P. Nelli, Enrico Aitini, C. Noberasco, C.P. Lui, L. Beckman, Yoichi Ikeda, Masakuni Noguchi, Sylvie Mazoyer, Ann-Lii Cheng, Masaki Mori, Arnaldo C. Medeiros, Alberto Ravaioli, Franco Desiderio, Franco Frigerio, Junkichi Kim, Gabriele Tancini, Takao Suzuki, Franco Rovelli, A. Bono, Tatsuro Kamakura, Maria Mitzi Brentani, G. Nastasi, Lurdes A. Marques, Massimo Franchi, Fernando Brivio, B. Müller, A. Di Leo, Kun-Huei Yeh, E. Jäger, Hiroshi Nakano, Giovanna Cavazzini, C. Fan, Pier Paolo Fattori, Mitsuharu Earashi, Marina Cazzaniga, U. Stendahl, Flavia Zanaboni, Kazuo Kinoshita, M. Nicolini, F. Gaion, Mikio Makuuchi, Hideaki Nagasaki, Hwei-Fang Tien, Paolo Lissoni, Einar K. Rofstad, Keizo Sugimachi, F. Cappuzzo, E. Bichisao, Maria Aparecida Nagai, Theorickus C. Viljoen, A Tusei, S.K. Kong, N. Zilembo, K.P. Fung, Giuseppina Arcangeli, C.Y. Lee, Haruki Oomori, M. Colleoni, Sandro Barni, N. Stjernberg, Kaoru Kumada, E. Pasquini, Seizo Minagawa, Mauro Moroni, P. Manente, Heidi Lyng, Franco Monti, Casper H. van Aswegen, A. Knuth, Camillo Porta, Maria Enrica Forghieri, Dion J. du Plessis, G. Sgarbossa, O. Klein, Haruo Tateishi, B. Wächter, Jun Sasaki, E. Bajetta, E. Scorbati, Lois M. Mulligan, Itsuo Miyazaki, Masahide Minami, Nicoletta Donadello, Lorenzo Gianni, Kimio Namatame, Antonio Ardizzoia, C. Bartoli, Y.M. Choy, Nobuhiro Koyanagi, U. Braun

Publikováno v: Oncology. 52:I-VI

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::443c498df9bb22a18ba1293f09664cec
https://doi.org/10.1159/000227505

A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) group

Autor: E, Bajetta, N, Zilembo, S, Barni, C, Noberasco, A, Martinetti, L, Ferrari, G, Schieppati, R, Buzzoni, A, Jirillo, M, Amichetti, M, D'Aprile, G, Comella, E, Bichisao, G F, Bolelli, A, Attili, E, Bombardieri

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology. 8(7)

In postmenopausal breast cancer (BC) patients, tamoxifen (TAM) is frequently used in first-line therapy, and for those relapsing under TAM, aromatase inhibitors would be the drug of choice. Formestane, a new aromatase inhibitor, has been demonstrated

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::e1c6c56d29c2bda040d2ae3badae57fd
https://pubmed.ncbi.nlm.nih.gov/9296217

Formestane: effective therapy in postmenopausal women with advanced breast cancer

Autor: E, Bajetta, N, Zilembo, R, Buzzoni, C, Noberasco, A, Martinetti, L, Ferrari, C, Bartoli, V, Sacchini, A, Attili, P, Lepera

Publikováno v: Annals of oncology : official journal of the European Society for Medical Oncology. 5

Aromatase inhibitors are a useful therapeutic option in the management of endocrine-dependent advanced breast cancer. Formestane (Lentaron) is the first irreversible aromatase inhibitor to be extensively investigated. In a phase II study to determine

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::3316a3a841989a360917b602d6a0a831
https://pubmed.ncbi.nlm.nih.gov/7873456